Research Article
Congenital Hepatic Fibrosis in Children and Adults: Clinical Manifestations, Management, and Outcome—Case Series and Literature Review
Table 1
Basic clinical information of 8 cases with different onset ages.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations and normal range of each lab index in parentheses: P = patient; M = male; F = female; yr = years old; CHF = congenital hepatic fibrosis; CHB = chronic hepatitis B; CBA = congenital biliary atresia; PFIC3 = progressive familial intrahepatic cholestasis-type 3; Hb = hemoglobin (male: 130-175 g/L, female: 115-150 g/L); WBC = white blood cell (-); PLT = platelet (-); ALT = alanine aminotransferase (male: 9-50 U/L, female: 7-40 U/L); AST = aspartate aminotransferase (male: 15-40 U/L, female: 13-35 U/L); ALP = alkaline phosphatase (1~4 yrs: <281 U/L; 5~6 yrs: <269 U/L; 7~12 yrs: <300 U/L; male 13~17 yrs: <390 U/L; male 18~19 yrs: 40-129 U/L; : 45-125 U/L; female 13~17 yrs: <187 U/L; female 18~19 yrs: 35-104 U/L; female 20~49 yrs: 35-100 U/L; female 50~79 yrs: 35-100 U/L; and : 50-135 U/L); GGT = γ-glutamyl transpeptidase (male: 10-60 U/L, female: 7-45 U/L); TBil = total bilirubin (3.4-20.4 μmol/L); INR = international normalized ratio (0.88-1.12); Alb = albumin (40-55 g/L). §CHF: combined with liver decompensation; §§polycystic kidneys combined with chronic renal dysfunction; IDA: iron deficiency anemia; RA: renal anemia. |